These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Phosphate binders prevent phosphate-induced cellular senescence of vascular smooth muscle cells and vascular calcification in a modified, adenine-based uremic rat model. Yamada S; Tatsumoto N; Tokumoto M; Noguchi H; Ooboshi H; Kitazono T; Tsuruya K Calcif Tissue Int; 2015 Apr; 96(4):347-58. PubMed ID: 25511229 [TBL] [Abstract][Full Text] [Related]
4. High phosphate and calcium induce osteoblastic phenotype switching and calcification of corneal epithelial cells in a Runx2-dependent and synergistic manner; a possible mechanism of chronic kidney disease-associated corneal calcification. Ababneh H; Tóth A; Lente G; Balogh E; Csiki DM; Nagy B; Szöőr Á; Jeney V Biochim Biophys Acta Mol Basis Dis; 2024 Jun; 1870(5):167171. PubMed ID: 38631411 [TBL] [Abstract][Full Text] [Related]
5. Calcification of the internal pudendal artery and development of erectile dysfunction in adenine-induced chronic kidney disease: a sentinel of systemic vascular changes. Maio MT; McCabe KM; Pruss CM; Pang JJ; Laverty K; Holden RM; Adams MA J Sex Med; 2014 Oct; 11(10):2449-65. PubMed ID: 25138987 [TBL] [Abstract][Full Text] [Related]
6. Metformin prevents the development of severe chronic kidney disease and its associated mineral and bone disorder. Neven E; Vervaet B; Brand K; Gottwald-Hostalek U; Opdebeeck B; De Maré A; Verhulst A; Lalau JD; Kamel S; De Broe ME; D'Haese PC Kidney Int; 2018 Jul; 94(1):102-113. PubMed ID: 29716795 [TBL] [Abstract][Full Text] [Related]
7. Liver and spleen predominantly mediate calciprotein particle clearance in a rat model of chronic kidney disease. Zeper LW; Bos C; Leermakers PA; Franssen GM; Raavé R; Hoenderop JGJ; de Baaij JHF Am J Physiol Renal Physiol; 2024 Apr; 326(4):F622-F634. PubMed ID: 38420675 [TBL] [Abstract][Full Text] [Related]
8. Integral pharmacological management of bone mineral disorders in chronic kidney disease (part I): from treatment of phosphate imbalance to control of PTH and prevention of progression of cardiovascular calcification. Bover J; Ureña-Torres P; Lloret MJ; Ruiz-García C; DaSilva I; Diaz-Encarnacion MM; Mercado C; Mateu S; Fernández E; Ballarin J Expert Opin Pharmacother; 2016 Jun; 17(9):1247-58. PubMed ID: 27156993 [TBL] [Abstract][Full Text] [Related]
11. Endothelin type A receptor blockade reduces vascular calcification and inflammation in rats with chronic kidney disease. Larivière R; Gauthier-Bastien A; Ung RV; St-Hilaire J; Mac-Way F; Richard DE; Agharazii M J Hypertens; 2017 Feb; 35(2):376-384. PubMed ID: 28005706 [TBL] [Abstract][Full Text] [Related]
12. Development of experimental chronic kidney disease and vascular calcification alters diurnal variation of phosphate and its hormonal regulators. Svajger BA; Riddoch JLH; Pruss CM; Laverty KJ; Ward E; Holden RM; Adams MA Physiol Rep; 2020 Nov; 8(21):e14626. PubMed ID: 33190417 [TBL] [Abstract][Full Text] [Related]
13. Phosphate toxicity and vascular mineralization. Razzaque MS Contrib Nephrol; 2013; 180():74-85. PubMed ID: 23652551 [TBL] [Abstract][Full Text] [Related]
14. Effect of cross-linked chitosan iron (III) on vascular calcification in uremic rats. de Castro BBA; do Carmo WB; de Albuquerque Suassuna PG; Carminatti M; Brito JB; Dominguez WV; de Oliveira IB; Jorgetti V; Custodio MR; Sanders-Pinheiro H Exp Biol Med (Maywood); 2018 May; 243(9):796-802. PubMed ID: 29763365 [TBL] [Abstract][Full Text] [Related]
15. CKD, arterial calcification, atherosclerosis and bone health: Inter-relationships and controversies. Reiss AB; Miyawaki N; Moon J; Kasselman LJ; Voloshyna I; D'Avino R; De Leon J Atherosclerosis; 2018 Nov; 278():49-59. PubMed ID: 30253289 [TBL] [Abstract][Full Text] [Related]
16. Apelin: A novel inhibitor of vascular calcification in chronic kidney disease. Han X; Wang LY; Diao ZL; Liu WH Atherosclerosis; 2016 Jan; 244():1-8. PubMed ID: 26581047 [TBL] [Abstract][Full Text] [Related]
17. Vascular, valvular and kidney calcification manifested in mouse models of adenine-induced chronic kidney disease. Yang X; Liu Y; Zhu X; Chen P; Xie X; Xu T; Zhang X; Zhao Y Ren Fail; 2023 Dec; 45(1):2228920. PubMed ID: 37369635 [TBL] [Abstract][Full Text] [Related]
18. Increased FGF23 protects against detrimental cardio-renal consequences during elevated blood phosphate in CKD. Clinkenbeard EL; Noonan ML; Thomas JC; Ni P; Hum JM; Aref M; Swallow EA; Moe SM; Allen MR; White KE JCI Insight; 2019 Feb; 4(4):. PubMed ID: 30830862 [TBL] [Abstract][Full Text] [Related]
19. R-568 reduces ectopic calcification in a rat model of chronic kidney disease-mineral bone disorder (CKD-MBD). Moe SM; Seifert MF; Chen NX; Sinders RM; Chen X; Duan D; Henley C; Martin D; Gattone VH Nephrol Dial Transplant; 2009 Aug; 24(8):2371-7. PubMed ID: 19258382 [TBL] [Abstract][Full Text] [Related]
20. Vascular calcification is associated with Wnt-signaling pathway and blood pressure variability in chronic kidney disease rats. Liao R; Wang L; Li J; Sun S; Xiong Y; Li Y; Han M; Jiang H; Anil M; Su B Nephrology (Carlton); 2020 Mar; 25(3):264-272. PubMed ID: 31709686 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]